Dr.Jaume Capdevila (Clinical oncologist)– Best Costs, Reviews – Book Your Consultation

Professional Experience

• Current Roles: Head of Gastrointestinal & Endocrine Tumor Unit at Teknon Cancer Institute (since 2013); Senior clinical oncologist at VHIO and Vall d’Hebron University Hospital (since 2006)
• Previous Role: Medical oncologist at Santa Creu i Sant Pau (2002–2006)
• Clinical Trials & Leadership: Leading early drug development and national/international clinical trials

Academic Contributions

• Researcher at Vall d’Hebron Institute of Oncology (VHIO), contributing to translational oncology
• Speaker at national and international oncology conferences
• Mentor to oncology fellows and participants in clinical development programs
• Active in networks focused on gastrointestinal and endocrine tumor research

Areas of Expertise

• Digestive tract cancers: Esophageal, gastric, colorectal, liver, pancreatic, biliary, small intestine, peritoneal, and anal canal tumors
• Endocrine & neuroendocrine tumors: Thyroid, gastroenteropancreatic NETs, paragangliomas, pheochromocytomas, and adrenal carcinoma
• Targeted therapies & clinical protocols: Personalized medicine and early-phase drug studies

Publications and Research

Dr. Capdevila has authored over 250 peer-reviewed publications and contributed to influential clinical trials:

• NETTER-2 trial (177Lu‑DOTATATE vs octreotide) — pivotal phase III study in neuroendocrine tumors (2024)
• ENETS lung NET task force survey on carcinoid management (2024)
• COMPOSE trial — genetic profiling in aggressive GEP‑NETs (2023)

Patient Care Philosophy

• Patient-centered communication: Involves patients in decision-making and explains treatment plans clearly
• Compassion and empathy: Supports patients with digestive and endocrine tumors throughout their journey
• International accessibility: Offers online consultations for remote patients seeking specialized oncology care

Professional Affiliations

• Member, European Organization for Research and Treatment of Cancer (EORTC)
• Member, European Society for Medical Oncology (ESMO)
• Member, European Neuroendocrine Tumor Society (ENETS); Advisory Board member
• Member, American Society of Clinical Oncology (ASCO)
• Co‑founder & Treasurer, Spanish Task Force for Orphan/ Rare Tumors (GETHI)
• Secretary & Treasurer, Spanish Neuroendocrine Tumor Group (GETNE)
• Member, Spanish Society of Medical Oncology (SEOM)

FAQs

Is Dr. Jaume Capdevila board-certified?

Yes. He is fully certified in medical oncology and specializes in gastrointestinal and endocrine cancers.

What types of cancers does he treat?

He treats digestive tract tumors (colon, pancreatic, liver, stomach) and endocrine/neuroendocrine tumors (thyroid, NETs, paraganglioma).

Does he treat international patients?

Yes. He offers secure online consultations and remote case evaluations.

How long is a typical hospital stay?

Length varies by treatment, but many outpatient and systemic therapies require minimal inpatient time.

What languages does he speak?

Dr. Capdevila speaks Spanish and English fluently.

Can I get involved in a clinical trial?

Yes. He leads early-phase clinical trials and can discuss trial options suitable for your condition.

How do I prepare for an online consultation?

You can submit medical reports via Teknon’s international desk prior to scheduling the online session.